These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1054 related articles for article (PubMed ID: 29743203)

  • 61. Localization of PPM1H phosphatase tunes Parkinson's disease-linked LRRK2 kinase-mediated Rab GTPase phosphorylation and ciliogenesis.
    Yeshaw WM; Adhikari A; Chiang CY; Dhekne HS; Wawro PS; Pfeffer SR
    Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2315171120. PubMed ID: 37889931
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Role of LRRK2 in Intracellular Organelle Dynamics.
    Boecker CA
    J Mol Biol; 2023 Jun; 435(12):167998. PubMed ID: 36764357
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cells.
    Thirstrup K; Dächsel JC; Oppermann FS; Williamson DS; Smith GP; Fog K; Christensen KV
    Sci Rep; 2017 Aug; 7(1):10300. PubMed ID: 28860483
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mechanisms of
    Sargent D; Moore DJ
    Int Rev Mov Disord; 2021; 2():221-244. PubMed ID: 35497708
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The impact of VPS35 D620N mutation on alternative autophagy and its reversal by estrogen in Parkinson's disease.
    Shiraishi T; Bono K; Hiraki H; Manome Y; Oka H; Iguchi Y; Okano HJ
    Cell Mol Life Sci; 2024 Feb; 81(1):103. PubMed ID: 38409392
    [TBL] [Abstract][Full Text] [Related]  

  • 66. LRRK2 phosphorylation status and kinase activity regulate (macro)autophagy in a Rab8a/Rab10-dependent manner.
    Kania E; Long JS; McEwan DG; Welkenhuyzen K; La Rovere R; Luyten T; Halpin J; Lobbestael E; Baekelandt V; Bultynck G; Ryan KM; Parys JB
    Cell Death Dis; 2023 Jul; 14(7):436. PubMed ID: 37454104
    [TBL] [Abstract][Full Text] [Related]  

  • 67. RAB8, RAB10 and RILPL1 contribute to both LRRK2 kinase-mediated centrosomal cohesion and ciliogenesis deficits.
    Lara Ordónez AJ; Fernández B; Fdez E; Romo-Lozano M; Madero-Pérez J; Lobbestael E; Baekelandt V; Aiastui A; López de Munaín A; Melrose HL; Civiero L; Hilfiker S
    Hum Mol Genet; 2019 Nov; 28(21):3552-3568. PubMed ID: 31428781
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genotype-phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic review.
    Trinh J; Zeldenrust FMJ; Huang J; Kasten M; Schaake S; Petkovic S; Madoev H; Grünewald A; Almuammar S; König IR; Lill CM; Lohmann K; Klein C; Marras C
    Mov Disord; 2018 Dec; 33(12):1857-1870. PubMed ID: 30357936
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of the VPS35 D620N mutation in Parkinson's disease.
    Mohan M; Mellick GD
    Parkinsonism Relat Disord; 2017 Mar; 36():10-18. PubMed ID: 27964832
    [TBL] [Abstract][Full Text] [Related]  

  • 70. LRRK2 kinase in Parkinson's disease.
    Alessi DR; Sammler E
    Science; 2018 Apr; 360(6384):36-37. PubMed ID: 29622645
    [No Abstract]   [Full Text] [Related]  

  • 71. Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson's disease VPS35 mutation p.D620N.
    Munsie LN; Milnerwood AJ; Seibler P; Beccano-Kelly DA; Tatarnikov I; Khinda J; Volta M; Kadgien C; Cao LP; Tapia L; Klein C; Farrer MJ
    Hum Mol Genet; 2015 Mar; 24(6):1691-703. PubMed ID: 25416282
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Parkinson's disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4.
    Funk N; Munz M; Ott T; Brockmann K; Wenninger-Weinzierl A; Kühn R; Vogt-Weisenhorn D; Giesert F; Wurst W; Gasser T; Biskup S
    Sci Rep; 2019 Mar; 9(1):4515. PubMed ID: 30872638
    [TBL] [Abstract][Full Text] [Related]  

  • 73. VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's disease.
    Chen X; Tsika E; Levine N; Moore DJ
    Mol Neurodegener; 2023 Aug; 18(1):51. PubMed ID: 37542299
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impaired Sonic Hedgehog Responsiveness of Induced Pluripotent Stem Cell-Derived Floor Plate Cells Carrying the LRRK2-I1371V Mutation Contributes to the Ontogenic Origin of Lower Dopaminergic Neuron Yield.
    Potdar C; Jagtap S; Singh K; Yadav R; Pal PK; Datta I
    Stem Cells Dev; 2024 Jun; 33(11-12):306-320. PubMed ID: 38753688
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Parkinson's disease-associated pathogenic VPS35 mutation causes complex I deficits.
    Zhou L; Wang W; Hoppel C; Liu J; Zhu X
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2791-2795. PubMed ID: 28765075
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice.
    Ishizu N; Yui D; Hebisawa A; Aizawa H; Cui W; Fujita Y; Hashimoto K; Ajioka I; Mizusawa H; Yokota T; Watase K
    Hum Mol Genet; 2016 Oct; 25(20):4507-4517. PubMed ID: 28173004
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain.
    Xu E; Boddu R; Abdelmotilib HA; Sokratian A; Kelly K; Liu Z; Bryant N; Chandra S; Carlisle SM; Lefkowitz EJ; Harms AS; Benveniste EN; Yacoubian TA; Volpicelli-Daley LA; Standaert DG; West AB
    Mol Neurodegener; 2022 Jan; 17(1):7. PubMed ID: 35012605
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Cell Biology of LRRK2 in Parkinson's Disease.
    Usmani A; Shavarebi F; Hiniker A
    Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33526455
    [TBL] [Abstract][Full Text] [Related]  

  • 79. (D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model.
    Chiu CC; Weng YH; Huang YZ; Chen RS; Liu YC; Yeh TH; Lu CS; Lin YW; Chen YJ; Hsu CC; Chiu CH; Wang YT; Chen WS; Liu SY; Wang HL
    Cell Death Dis; 2020 Nov; 11(11):1018. PubMed ID: 33257649
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease.
    Taylor M; Alessi DR
    Curr Opin Cell Biol; 2020 Apr; 63():102-113. PubMed ID: 32036294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.